EN
Edward Nash Canaccord Genuity Latest Price Targets & Analyst Ratings
| Stock | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|
1
Celldex Therapeutics
CLDX
$1.55B
| $24.30 | $62 |
155%
upside
| Buy |
20 Aug ‘25
21 days ago |
|
2
Madrigal Pharmaceuticals
MDGL
$10.1B
| $448.73 | $428 |
5%
downside
| Buy |
6 Aug ‘25
1 month ago |
|
3
Corcept Therapeutics
CORT
$7.51B
| $71.73 | $137 |
91%
upside
| Buy |
1 Aug ‘25
1 month ago |
|
4
Sagimet Biosciences
SGMT
$229M
| $6.89 | $28 |
306%
upside
| Buy |
24 Jul ‘25
1 month ago |
|
|
VRNA
5
Verona Pharma
VRNA
$9.19B
| $106.30 | $107 |
1%
upside
| Hold |
9 Jul ‘25
2 months ago |
|
6
Travere Therapeutics
TVTX
$1.93B
| $21.64 | $47 |
117%
upside
| Buy |
10 Apr ‘25
5 months ago |
|
7
Rani Therapeutics
RANI
$23.9M
| $0.4994 | $9 |
1,702%
upside
| Buy |
26 Feb ‘25
6 months ago |
|
8
Pliant Therapeutics
PLRX
$107M
| $1.75 | $4 |
129%
upside
| Hold |
10 Feb ‘25
7 months ago |
|
9
Akero Therapeutics
AKRO
$3.57B
| $44.62 | $73 |
64%
upside
| Buy |
28 Jan ‘25
7 months ago |
|
10
Apogee Therapeutics
APGE
$2.29B
| $38.46 | $89 |
131%
upside
| Buy |
25 Nov ‘24
9 months ago |
|
11
Ventyx Biosciences
VTYX
$170M
| $2.38 | $14 |
488%
upside
| Buy |
12 Aug ‘24
1 year ago |
|
|
CRDL
12
Cardiol Therapeutics
CRDL
$87.9M
| $1.03 | $8 |
677%
upside
| Buy |
23 May ‘24
1 year ago |
|
|
IVA
13
Inventiva
IVA
$747M
| $5.36 | $20 |
273%
upside
| Buy |
8 Apr ‘24
1 year ago |
|
|
THTX
14
Theratechnologies
THTX
$150M
| $3.27 | $8 |
145%
upside
| Hold |
3 Jul ‘23
2 years ago |
|
15
Rezolute
RZLT
$703M
| $8.08 | $17 |
110%
upside
| Buy |
19 May ‘23
2 years ago |
|
16
Oramed Pharmaceuticals
ORMP
$94.3M
| $2.31 | $2 |
13%
downside
| Hold |
17 May ‘23
2 years ago |
|
17
Galmed Pharmaceuticals
GLMD
$8M
| $1.46 | $180 |
12,229%
upside
| Hold |
8 Aug ‘22
3 years ago |
|
18
Ultragenyx Pharmaceutical
RARE
$3.04B
| $31.50 | $82 |
160%
upside
| Buy |
19 Jun ‘20
5 years ago |
|